QuickView for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=38C26B15A34919197C7BA18757707959;jsessionid=42AE9637B0C584911FA4F6FAA193DF89;jsessionid=D2167CD42F840F0A30F7884B3273F7C7;jsessionid=DC041CC5DAAE47E4B6A1D37264108C81;jsessionid=CF9E353FBA84B51D2B8BEBF21ABC9BB9 (gene)

1. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
2. Irreversible Antagonists for the Adenosine A2B Receptor.
3. A patent review of adenosine A2B receptor antagonists (2016-present).
4. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Can…

There were no clinical trials for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=38C26B15A34919197C7BA18757707959;jsessionid=42AE9637B0C584911FA4F6FAA193DF89;jsessionid=D2167CD42F840F0A30F7884B3273F7C7;jsessionid=DC041CC5DAAE47E4B6A1D37264108C81;jsessionid=CF9E353FBA84B51D2B8BEBF21ABC9BB9